Related Experiment Video

Updated: Jun 27, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Cardiac recovery during mechanical assist device support

Simon Maybaum1, Gayathri Kamalakannan, Sandhya Murthy

  • 1Department of Medicine, Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York 10467, USA. smaybaum@montefiore.org

Seminars in Thoracic and Cardiovascular Surgery
|November 29, 2008
PubMed

Insights

Temporary mechanical support with left ventricular assist devices (LVADs) may allow native heart recovery in advanced heart failure patients. This approach offers a potential alternative to transplantation or long-term device support.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Regenerative Medicine

Background:

  • Advanced heart failure affects many patients, with limited donor hearts available for transplantation.
  • Current treatments like cardiac transplantation and long-term left ventricular assist device (LVAD) therapy have significant complications.
  • Investigational approaches focus on temporary LVAD use to facilitate native heart recovery.

Purpose of the Study:

  • To review the impact of LVAD support on the pathophysiology of end-stage heart failure.
  • To outline clinical evidence of cardiac recovery in patients supported by LVADs.
  • To describe methods for assessing cardiac function and criteria for device explantation in recovery-oriented LVAD therapy.

Main Methods:

  • Review of existing literature on LVAD support and cardiac recovery.
  • Analysis of clinical data from patients with advanced heart failure treated with LVADs.
  • Description of functional assessment techniques and explantation criteria.

Main Results:

  • LVAD support may reverse cellular and functional deficits in end-stage heart failure.
  • Evidence suggests that the native heart can recover function during LVAD support.
  • Specific techniques and criteria for evaluating recovery and device explantation are being developed.

Conclusions:

  • Temporary LVAD support holds promise for enabling native heart recovery in advanced heart failure.
  • This strategy could offer an alternative to cardiac transplantation or permanent mechanical support.
  • Further research and clinical validation are needed to optimize patient selection and management for cardiac recovery.

More Related Videos

Implantation of the Syncardia Total Artificial Heart16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.